You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
17 April 2024
Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera
8 February 2024
Spexis announces closing of sale of preclinical antibiotics program to Basilea
15 January 2024
Spexis announces sale of preclinical antibiotics program to Basilea
5 December 2023
Spexis is Granted Debt-Restructuring Moratorium
29 November 2023
Spexis Provides Update Regarding Debt-Restructuring Moratorium
8 November 2023
Spexis to file an application for a debt-restructuring moratorium